Although recent scientific and medical breakthroughs have transformed many people’s lives, there is still quite a bit we do ...

[6] The authors stated that two-month treatment with trazodone ... statistically significant effect on fibromyalgia severity, depression, anxiety and pain interference with daily activities ...

The most challenging part of my recent pain journey was the uncertainty. But, as uncomfortable as it is, uncertainty also ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

Tonix Pharmaceuticals (NASDAQ: TNXP) through its subsidiary Tonix Medicines, has introduced two fast-acting migraine treatments, Zembrace® SymTouch ...

CHATHAM, N.J., Nov. 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical ...

A delay in antibiotic treatment can make the disease more difficult to treat and may result in chronic symptoms and pain, so ...

While many people living with chronic pain require medication, there is growing interest in non-pharmacological approaches ...

Detailed price information for Neurometrix Inc (NURO-Q) from The Globe and Mail including charting and trades.

Patent application paves the way for a potential breakthrough in chronic pain treatment, offering renewed hope for ...

The Company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain ...

'Non-oral migraine medications, such as injectables and nasal sprays, do not rely on the digestive system to be absorbed and can offer the potential for faster relief from migraine symptoms in as ...